It was found that JACK 7.1 can be used to analyze ergonomic risks in long, and low-volume assembly processes. However, the ...

A Rapport Therapeutics seizure medicine succeeded in a mid-stage clinical trial, sending company shares soaring.

Shares of Rapport Therapeutics popped Monday morning after Phase IIa data for RAP-219 exceeded analyst and Wall Street ...

Rapport Therapeutics, Inc.'s RAP-219 shows strong Phase 2a results for drug-resistant seizures, boosting stock and optimism.

Early lessons in research managment at Xerox PARC have stood the test of time. Early in my career, I had the opportunity to ...